Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000929624-01-500151
Filing Date
2001-04-30
Accepted
2001-04-30 00:00:00
Documents
7
Period of Report
2000-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K AMENDMENT #1 d10ka.txt 10-K/A 263919
2 EMPLOYMENT AGREEMENT WITH JAMES BIANCO dex105a.txt EX-10.5(A) 23845
3 SEVERANCE AGREEMENT WITH LOUIS BIANCO dex106a.txt EX-10.6(A) 14956
4 SEVERANCE AGREEMENT WITH SUSAN MOORE dex107.txt EX-10.7 13337
5 SEVERANCE AGREEMENT WITH JACK SINGER dex108a.txt EX-10.8(A) 14858
6 SEVERANCE AGREEMENT WITH EDWARD KENNEY dex109.txt EX-10.9 13279
7 CONSENT OF ERNST & YOUNG, LLP INDEPENDENT AUDITORS dex231.txt EX-23.1 1057
  Complete submission text file 0000929624-01-500151.txt   347441
Mailing Address
Business Address 201 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062707100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

EIN.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-12465 | Film No.: 1616674
SIC: 2834 Pharmaceutical Preparations